Exhibit 99.1

================================================================================
                                 FONAR CORPORATION

Fonar  MRI news @ aol . com                              Inventor of MR Scanning
For    Immediate    Release                              An   ISO  9001  Company

Contact:    Daniel  Culver,                              110    Marcus     Drive
Director of  Communications                              Melville,  N.Y.   11747
Web site:     www.fonar.com                              Tel:   (631)   694-2929
Email: invest2007@fonar.com                              Fax:   (631)   390-1709
================================================================================

 FONAR Announces Third Quarter and Nine-Month Financial Results for Fiscal 2007

     MELVILLE,  NEW YORK, May 11, 2007 - FONAR Corporation  (NASDAQ-FONRD),  The
Inventor  of MR  Scanning(TM),  announced  its  financial  results for the third
quarter of fiscal 2007, which ended March 31, 2007.

     For the  nine-month  period ended March 31, 2007, we reported a net loss of
$17.0  million on  revenues  of $24.2  million as  compared to net loss of $21.0
million on revenues of $27.8 million for the  nine-month  period ended March 31,
2006.

     For the three month  period  ended March 31, 2007 we reported a net loss of
$5.4 million on revenues of $8.8 million as compared to net loss of $7.4 million
on revenues of $7.1 million for the three-month period ended March 31, 2006.

     Net loss and revenue for the quarter  ending  March 31, 2007 as compared to
the quarter ended March 31, 2006. Net losses  improved by 26.6%,  ($5.4 million)
as compared to ($7.4  million),  on a revenue  increase of 23.6% to $8.8 million
from $7.1 million. Particularly noteworthy was that the revenues for the quarter
ending  March 31, 2007  accounted  for 36.2% of the  revenues of the  nine-month
period ending March 31, 2007.

     There was recent  increased  sales  activity which  management  believes is
attributable to a general increase in the utilization of MRI and the increase in
demand for UPRIGHT(TM) MRI scans, and the reduction of uncertainty of the impact
of the Deficit  Reduction Act ("DRA").  A recent survey of FONAR UPRIGHT(TM) MRI
customers  shows the DRA has not had a  substantial  impact on revenues  and has
been more than offset by an increase in utilization  of MRI and the  UPRIGHT(TM)
imaging technology.

     During the third fiscal 2007 quarter, total product sale revenues were $3.2
million,  an increase of 91% from $1.7 million one year earlier.  The nine-month
total  product  sales for the quarter  ending March 31, 2007 was $7.8 million as
compared to $10.0 million for the same period one year earlier.

     Service and repair revenues for the third fiscal 2007 quarter increased 10%
to $2.6 million from $2.3  million  during the same quarter of fiscal 2006.  For
the  nine-month  period  ending  March 31, 2007 there was a 18% increase to $7.5
million from $6.3 million for the same period one year earlier.  These increases
are due to the result and initiation of service contract  agreements from recent
installations of FONAR UPRIGHT (TM) Multi- Position(TM) MRI units.

     During the third fiscal  quarter  total costs related to service and repair
fees were $1.3  million as compared to $1.4 million one year  earlier.  Also for
the  nine-month  period total costs related to service and repair fees were $3.9
million as compared  to $4.2  million one year  earlier.  As of March 31,  2007,
there  were  118  FONAR  UPRIGHT(TM)   Multi-Position(TM)  MRI  units  installed
worldwide.

     At March 31, 2007,  total assets were $48.5  million,  total current assets
were $30.2  million,  total cash and  marketable  securities  were $5.8 million,
total current  liabilities were $29.2 million,  and total long-term  liabilities
were $1.3 million.

     Dr. Raymond Damadian, president and chairman of FONAR, said, "the future of
UPRIGHT(TM)  Multi-Position(TM)  Full Range of  Motion(TM)  MRI is more exciting
than  ever.  Unique  medical  applications  for  UPRIGHT(TM)  Multi-Position(TM)
imaging arise continuously.  A very important example is FONAR's new development
of scanning  protocols for scoliosis.  According to a National Cancer  Institute
study  published in 2000,  women with scoliosis  have a 90% higher  incidence of
developing breast cancer than non-scoliotic  women, the apparent cause being the
repeated multiple chest X-rays over many years required for scoliosis  treatment
and  treatment  monitoring.   Upright,  full  weight-bearing  chest  X-rays  are
mandatory to evaluate  scoliosis.  UPRIGHT(TM)  MRI meets the scoliosis need for
upright imaging without the radiation and without the risk of engendering breast
cancers. The estimated number of children in North America with scoliosis is 1.5
million,  a number which does not include scoliosis patients above age 18, which
raise the number with scoliosis to 3.0 million."

     MRI scans for the detection of silicone breast implant leaks is another new
application of UPRIGHT(TM)  MRI," continued Dr. Damadian.  "Silicon implants for
breast  augmentation were only recently  reinstated by the FDA in November 2006.
The FDA recommends  that MRI scans be performed for leakage  detection at year 1
and year 2, and alternate years thereafter for 8 more years.  Cosmetic  surgeons
deem it important  that these scans be done upright to optimize the detection of
implant leaks.  Pooling of implant material when the breast is gravity-dependent
and pendant is perceived to be the most sensitive  means for image  detection of
leakage.  There is concern that when the breast is recumbent  redistribution  of
leakage material may undermine detection.  There are currently in excess of 1.65
million  women in the U.S.  with  breast  implants.  Under  the new FDA  leakage
monitoring  recommendations,  1.65 million women would require MRI  examinations
annually for each of the first two years and then every other year thereafter."

     "The  current  installed  base of  FONAR  UPRIGHT(TM)  MRI  scanners  (118)
operating at maximum capacity," added Dr. Damadian, "can accomplish only 614,000
of the needed 1.65 million MRI scans in each of the first two years  recommended
by the FDA and of the needed 1.65 million scans on alternate  years  thereafter,
even if these scanners were performing MRI breast examinations exclusively."

     "Whiplash injuries of the neck also require UPRIGHT(TM) Multi- Position(TM)
Full Range of Motion(TM) evaluation of the disks,  ligaments,  neck musculature,
vertebra and spinal cord for a satisfactory assessment of the neck injury," said
Dr. Damadian.  "There are currently 1,000,000 motor vehicle whiplash injuries of
the neck occurring annually."

     Dr. Damadian continued, "Patients with Chiari syndrome, in which the brain,
for lack of  sufficient  connective  tissue  support,  descends into the foramen
magnum  (opening) at the base of the skull when the patient is upright,  require
UPRIGHT(TM)  MR imaging.  The "drop  attacks"  that occur in this  syndrome  are
characterized  by a  sudden  episode  of  muscular  paralysis  and a  concurrent
"falling  to the  ground"  when the  patient is  upright.  The actual  pathology
initiating the "drop attack" can only  therefore be visualized  with the patient
in the same posture that prompts the  "attack".  Consequently,  Chiari  patients
require examination in the FONAR UPRIGHT(TM) MRI to achieve the images necessary
to assess the extent of Chiari malformation.  The current estimate of the number
of  Chiari  cases  in the  U.S.  is  300,000.  This  number  is  believed  to be
underestimated by as much as 200,000 Chiari 1 malformations now thought to occur
annually, secondary to motor vehicle whiplash injuries."

     "Such applications continue to arise without limit.  Moreover,  they are in
addition to the already existing extensive  musculoskeletal  applications in the
spine  wherein  1,000,000  spine  surgeries  are  performed  annually  and where
UPRIGHT(TM)  weight-bearing  Multi-Position(TM)  imaging  prior to surgery  will
ultimately be mandatory to prevent incorrect  surgery.  Additionally,  there are
9,000,000  MRI  scans of the  spine  performed  annually  in the  U.S.  that are
destined to become  UPRIGHT(TM)  Multi-  Position(TM) MRI scans so that accurate
identification  of the  patient's  symptom  generating  spine  pathology  can be
achieved.   And  ultimately  the  extensive   cardio-vascular   applications  of
UPRIGHT(TM)  Multi-  Position(TM)  imaging are  destined to come into use,  e.g.
UPRIGHT(TM)  imaging of cerebral blood flow prior to surgical  vascular  repair,
and  UPRIGHT(TM)  imaging of lower  extremities  varicosities  prior to surgery.
Additionally,  a little over 1,000,000 cardiac surgeries are performed  annually
in the U.S.  Such  patients  will benefit  substantially  from  UPRIGHT(TM)  MRI
imaging of coronary blood flow prior to deciding between the various  corrective
alternatives,  e.g. bypass, stents, and angioplasty," said Dr. Damadian.  "These
are but a few of the clinical conditions that are undiagnosable  without upright
scanning that have been brought to FONAR's  attention since the  introduction to
the  medical   community  by  FONAR  of   UPRIGHT(TM)   Multi-Position(TM)   MRI
technology."


                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                         For the Three Months           For the Nine Months
                            Ended March 31,                Ended March 31,
                          2007         2006             2007          2006
                      -----------   -----------     ------------   ------------
Revenues              $ 8,782,000   $ 7,103,000     $ 24,237,000   $ 27,797,000
Net Loss              $(5,401,000)  $(7,357,000)    $(16,976,000)  $(21,031,000)
Basic & Diluted Loss
per Common Share         $(1.11)     $(1.65)           $(3.52)       $(4.80)


The Inventor of MR Scanning(TM), Stand-Up(TM) MRI,  True Flow(TM) MRI,  PMRI(TM)
FONAR UPRIGHT(TM) MRI, Position(TM) MRI, and  The Proof is  in  the  Picture(TM)
                           are trademarks of FONAR.

Be sure to visit FONAR's Web site for Company product and investor  information:
                                 www.fonar.com

                                      ###
This release may include forward-looking statements from the company that may or
may  not  materialize.  Additional information on factors that could potentially
affect the  company's financial results may be found in the company filings with
the Securities and Exchange Commission.